3186 results for «8154»
3186 results
ACS - Identification and treatment of the culprit lesion
19 May 2023 – From EuroPCR 2023
Consult this session if you want to learn how to identify the culprit lesion , to learn about the use of IC imaging and physiological assessment, and to see the different treatment in different countries .
Hurdles in TAVI and dilemmas in CTO
19 May 2023 – From EuroPCR 2023
Consult this session if you want to learn how to recognise unexpected problems in TAVI, to learn to think out of the box for tackling unusual problems, and to learn how to know when to expect rare problems.
EuroPCR 2023 Hotlines/Late-Breaking Trials: focus on wire and image-based physiology
18 May 2023 – From EuroPCR 2023
Find out more about a series of studies focusing on wire and image based physiology: Coronary microvascular function and CT coronary angiography trial aiming to assess whether endotype diagnosis informed by coronay function testing vs angiography improved angina; a 5-year follow up of the DEFINE FLAIR;...
Multivessel disease PCI guided by physiology and intracoronary imaging - LIVE case
19 May 2023 – From EuroPCR 2023
A 68-year-old non-diabetic male patient presented with recent exertional chest pain and good LV function. Baseline angiography revealed severe stenosis of the proximal RCA, mid-stenosis of the proximal and mid-CX, and mid-stenosis of the proximal and mid-LAD.
Physiology revealed significant stenosis of proximal CX and proximal LAD.
IVUS...
EuroPCR 2023 Awards
19 May 2023 – From EuroPCR 2023
EuroPCR 2023 Hotlines/Late-Breaking Trials: from (N)STEMI to Chronic Coronary Syndromes (CCS)
19 May 2023 – From EuroPCR 2023
What are the most significant facts in this respect? Get the essentials by listening to the presenters review some clinical hotlines. To cite a few, Selective Intracoronary hypothermia in anterior wall myocardial infarction; real-time catheter-based microvascular obstruction detection in STEMI : results from the MOCCA I...
How did we do it in Argentina, Brazil, and Portugal?
19 May 2023 – From EuroPCR 2023
Consult this session if you want to evaluate the optimal strategy in complex bicuspid cases, and discuss the correct sizing algorithm depending on transcatheter heart valve selected, to manage infrequent but life-threatening complications using TAVI devices, and to improve your skills in TAVI long-term follow-up management.
Complex and high-risk PCI management
19 May 2023 – From EuroPCR 2023
This session discusses the comparison between high-risk PCI and repeat CABG, exploring current practices of high-risk PCI and strategies for optimizing outcomes in different scenarios, and examining the utilization of mechanical circulation support devices.
Embolic protection, TAVI, heart failure and artificial intelligence: what's new in 2023
19 May 2023 – From EuroPCR 2023
This session covers various topics related to transcatheter aortic valve replacement, including the Protect Head-to-Head study on full-body embolic protection during TAVR, the FLOWer device for complete embolic protection, the use of a pulsing aspiration pump for percutaneous thrombectomy, and many more innovation updates from 2023.
EuroPCR 2023 Grande Finale
19 May 2023 – From EuroPCR 2023
EuroPCR 2023 comes to a close with a selection of cases demonstrating the major human impact of interventions, not only on patients' clinical outcomes, but also on their families, and even on society itself. The idea is to follow the theme of this year's edition, which...
TAVI 1: durability, mismatch and challenging anatomy
18 May 2023 – From EuroPCR 2023
Explore TAVI longevity: Five-year Portico valve outcomes, bioprosthetic dysfunction post-surgery or self-expanding TAVI, prosthesis-patient mismatch impact, and innovative valve-in-valve TAVI insights, and more.
STEMI Vignettes - The global classroom
18 May 2023 – From EuroPCR 2023
Through these cases, explore global STEMI management and understand various geographic challenges and complication management approaches.
Shock with valve disease - Part 2
18 May 2023 – From EuroPCR 2023
In these slides, explore complex scenarios and complications of valve disease; from severe aortic regurgitatione to combined PCI and TAVI with ECMO support. Witness nightmare TAVI cases, the use of an urgent mitral clip, and many more.
Endovascular management treatment
17 May 2023 – From EuroPCR 2023
In this series of resources, explore the toolbox for BTK bifurcation treatment with antegrade and retrograde management, navigate complex scenarios in superficial femoral artery and femoral bifurcation and elevate your expertise in carotid artery stenting managment.
PCR's Got Talent - Round 2 - Session 2
17 May 2023 – From EuroPCR 2023
Join Round 2, Session 2 of PCR's Got Talent for insights into the safety and efficacy of protamine administration in TAVR patients with recent PCI.
How CTO techniques can help you in your everyday practice?
17 May 2023 – From EuroPCR 2023
Consult this session if you want to improve your skills in coronary intervention problem solving, to learn how techniques used in CTO PCI can solve problems in non-CTO PCI, and to discuss how to overcome PCI barriers and complications.
Where will the future of Robotics in Interventional Cardiology take us?
15 May 2023 – From PCR Innovators day 2023
Is only fixing functional mitral regurgitation in heart failure patients enough?
20 Nov 2023 – From PCR London Valves 2023
This session offers insights into combo therapy involving Carillon for patients with functional mitral regurgitation. It covers details of the EMPOWER trial, a double-blinded, sham-controlled study, and explores the potential benefits of early treatment for patients with functional mitral regurgitation.
Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...
19 Nov 2023 – From PCR London Valves 2023
Discover the mitral late-breaking trials which were presented during PCR London Valves 2023:
- One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
- AltaValve transseptal programme update
- Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
- Combined impact of mitral valve gradients and mitral regurgitation reduction...
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
